about
Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic Hepatitis.Mass spectrometric approach for screening modifications of total serum N-glycome in human diseases: application to cirrhosis.Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosisCorticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data.Immunoglobulins are the major glycoproteins involved in the modifications of total serum N-glycome in cirrhotic patients.The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids.Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis.Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis.Peroxisome proliferator-activated receptors in HBV-related infectionA histologic scoring system for prognosis of patients with alcoholic hepatitisAlcoholic liver disease: mechanisms of injury and targeted treatment.Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial.Main drivers of outcome differ between short and long-term in severe alcoholic hepatitis: A prospective study.Liver transplantation for patients with alcoholic hepatitis.Impact of emerging hepatitis C virus treatments on future needs for liver transplantation in France: a modelling approach.Sepsis in alcohol-related liver disease.Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration.Albumin Use in Patients With Cirrhosis in France: Results of the "ALBU-LIVE" Survey: A Case for Better EASL Guidelines Diffusion and/or Revision.Circulating levels of bacterial DNA and risk of infections in severe alcoholic hepatitis.Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: a case-control study.The Periscreen Strip Is Highly Efficient for the Exclusion of Spontaneous Bacterial Peritonitis in Cirrhotic Outpatients.Intensive Enteral Nutrition Is Ineffective for Patients With Severe Alcoholic Hepatitis Treated With Corticosteroids.Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial.Assessment of adrenal function in patients with acute hepatitis using serum free and total cortisol.Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: a modeling approach.M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease.Meta-analysis: the impact of IL28B polymorphisms on rapid and sustained virological response in HCV-2 and -3 patients.Neutrophil migration during liver injury is under nucleotide-binding oligomerization domain 1 control.[Chronic alcohol consumption and progress of hepatic lesions].Impact of pegylated interferon and ribavirin on morbidity and mortality in patients with chronic hepatitis C and normal aminotransferases in France.Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease.Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor.Effects of infliximab therapy on abdominal fat and metabolic profile in patients with Crohn's disease.[Therapeutic misadventure with acetaminophen in alcoholics].NOD2: a potential target for regulating liver injury.Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids.Tumor size of hepatocellular carcinoma in noncirrhotic liver: a controversial predictive factor for outcome after resection.Evaluation of laboratory tests for cirrhosis and for alcohol use, in the context of alcoholic cirrhosis.Transient elastography alone and in combination with FibroTest® for the diagnosis of hepatic fibrosis in alcoholic liver disease.
P50
Q30942640-4551395C-58F1-4360-B7C7-7375027E2B12Q33229025-1730B7EB-F864-47E2-84C7-17746E549B8CQ33464957-1B1517B4-59AB-4EEC-936B-D7760053A136Q33715940-854B6FAA-3126-4F64-8DA9-1D01260D31CCQ33764477-ED600D30-C9C0-44D0-A65E-A1CE93514A2DQ34630737-B2C57CEF-7255-4886-A82F-673327167D88Q35995445-41B76DF9-3DF3-4146-8080-CF03C1316C79Q36021982-C445C2D6-01C6-43B9-8246-6394610634EDQ37155874-322B8219-9693-46DE-BF74-D0C1E37DC5AFQ37710980-922E0382-760C-4B5A-9DC2-CFEAD0DA3B15Q38381594-203A3D72-D5C5-41FB-8417-2F6CA088B207Q38444803-53817AB1-E559-4073-A243-E5BD2A376D36Q38689141-9A925BEB-33F1-4EB8-A24F-5075F6F3212AQ38939884-D6D2DC55-3E5E-40C1-8C7F-C84AAA30E811Q39334223-2787EF89-B894-440A-8ECB-7DE40009565CQ39396505-A674C309-C8B5-4AFE-8952-ADF27AA50264Q40001901-AFAC6274-CABB-45FA-86FB-E5C27EC332B7Q40102067-29C31303-C72D-402C-8DF9-AA2EE2FD0115Q40116678-40CE91BC-3914-4E82-855B-4043275EC00DQ40224423-8B777A92-E3BE-48BC-A2C4-D4B1BC6FB14AQ40543189-BC3B6A61-784F-427F-A9E9-F6EC7BA2055CQ40978999-52143CD3-EB16-4B8E-99FB-9CBBEA1D7134Q41007436-DE2A9585-B690-455E-9B05-34B7C86221BBQ41625275-41BDAD3F-AAF1-4460-9308-C15EEE3E2FCBQ41666894-09FAF41B-54EA-4998-9EDE-B21150BC3B14Q42228465-4D47510F-B2AD-4EA1-BC9B-7ACDCCFAE781Q42710363-20C273C8-637B-40B4-90E5-22FD5DF970F3Q42981780-3CF340F9-72CC-4F43-B6F9-B85D75F67A2EQ43212687-614188ED-8583-4CEE-8EC1-5E848F8DE6ADQ43243283-C1782558-6B2F-4061-87AD-286997451572Q43292657-CCCD49C9-F3DA-4B76-A5F6-1EE7358E4256Q43538881-02D7F237-06D5-41E3-B87C-9B3D9BF69EDFQ45907288-649FD4B8-AF33-4B8D-BD55-9EFC1DB48955Q46085890-17F4E20C-097C-4707-BA6B-7976FECDDF37Q46300268-FF7F2893-3F16-438F-A460-3C7145E21C1EQ46785934-AB0FD630-EA1D-43B6-9AC5-7ECA4A517BE3Q46829230-A575A309-0FF2-4C1B-995F-BD484D3E0F56Q47293605-251A1BF1-535A-4447-95BA-3B4DD520413DQ47668959-6034DEF7-8AE6-4B0A-A402-75F133D2D287Q48306851-F2560BEE-C091-447F-84E0-5815F0BDA3CA
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Alexandre Louvet
@ast
Alexandre Louvet
@en
Alexandre Louvet
@es
Alexandre Louvet
@nl
type
label
Alexandre Louvet
@ast
Alexandre Louvet
@en
Alexandre Louvet
@es
Alexandre Louvet
@nl
prefLabel
Alexandre Louvet
@ast
Alexandre Louvet
@en
Alexandre Louvet
@es
Alexandre Louvet
@nl
P1053
S-4422-2018
P106
P31
P496
0000-0002-5293-007X